Immunosuppressive medications help prevent organ rejection following transplantation, yet some patients still experience rejection despite receiving adequate treatment. New research from Yale, published in the Journal of Clinical Investigation, identifies a potential genetic mechanism underlying the increased risk in some patients of recent African ancestry, revealing changes in immune cell signaling that may contribute to kidney transplant rejection.